These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1857223)

  • 1. Expression and purification of recombinant insulin-like growth factors from Escherichia coli.
    Nilsson B; Forsberg G; Hartmanis M
    Methods Enzymol; 1991; 198():3-16. PubMed ID: 1857223
    [No Abstract]   [Full Text] [Related]  

  • 2. Secretion of recombinant human insulin-like growth factor I (IGF-I).
    Brierley RA
    Methods Mol Biol; 1998; 103():149-77. PubMed ID: 9680639
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression of secreted insulin-like growth factor-1 in Escherichia coli.
    Wong EY; Seetharam R; Kotts CE; Heeren RA; Klein BK; Braford SR; Mathis KJ; Bishop BF; Siegel NR; Smith CE
    Gene; 1988 Sep; 68(2):193-203. PubMed ID: 3065142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a novel type of cloning vector for suicide selection of recombinants.
    Chan RY; Palfree RG; Congote LF; Solomon S
    DNA Cell Biol; 1994 Mar; 13(3):311-9. PubMed ID: 8172659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein engineering to optimize recombinant protein purification.
    Uhlén M; Moks T; Abrahmsén L
    Biochem Soc Trans; 1988 Apr; 16(2):111-2. PubMed ID: 3163658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual affinity fusion approach and its use to express recombinant human insulin-like growth factor II.
    Hammarberg B; Nygren PA; Holmgren E; Elmblad A; Tally M; Hellman U; Moks T; Uhlén M
    Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4367-71. PubMed ID: 2543972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene synthesis, expression in Escherichia coli and purification of immunoreactive human insulin-like growth factors I and II. Application of a modified HPLC separation technique for hydrophobic proteins.
    Hummel M; Herbst H; Stein H
    Eur J Biochem; 1989 Apr; 180(3):555-61. PubMed ID: 2469575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-level expression of human insulin-like growth factor II in Escherichia coli.
    Rhee HJ; Lee YI; Yang KH
    J Biotechnol; 1990 Mar; 13(4):293-304. PubMed ID: 1366560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of biologically active recombinant tilapia insulin-like growth factor-II polypeptides in Escherichia coli cells and characterization of the genomic structure of the coding region.
    Chen JY; Chang CY; Chen JC; Shen SC; Wu JL
    DNA Cell Biol; 1997 Jul; 16(7):883-92. PubMed ID: 9260931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escherichia coli peptide methionine sulfoxide reductase: cloning, high expression, and purification.
    Brot N; Rahman MA; Moskovitz J; Weissbach H
    Methods Enzymol; 1995; 251():462-70. PubMed ID: 7651229
    [No Abstract]   [Full Text] [Related]  

  • 11. Fusions to self-splicing inteins for protein purification.
    Xu MQ; Paulus H; Chong S
    Methods Enzymol; 2000; 326():376-418. PubMed ID: 11036654
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemical synthesis, cloning, and expression of genes for human somatomedin C (insulin-like growth factor I) and 59Val-somatomedin C.
    Niwa M; Sato S; Saito Y; Uchiyama F; Ono H; Yamashita M; Kitaguchi T; Shiga Y; Notani J; Yamada H
    Ann N Y Acad Sci; 1986; 469():31-52. PubMed ID: 3014978
    [No Abstract]   [Full Text] [Related]  

  • 13. The pRSET family of T7 promoter expression vectors for Escherichia coli.
    Schoepfer R
    Gene; 1993 Feb; 124(1):83-5. PubMed ID: 8440483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of heterologous proteins in Saccharomyces cerevisiae using the ADH2 promoter.
    Price VL; Taylor WE; Clevenger W; Worthington M; Young ET
    Methods Enzymol; 1990; 185():308-18. PubMed ID: 2116576
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression as trpE fusion.
    Yansura DG
    Methods Enzymol; 1990; 185():161-6. PubMed ID: 2199778
    [No Abstract]   [Full Text] [Related]  

  • 16. Overproduction of proteins in Escherichia coli: vectors, hosts, and strategies.
    Das A
    Methods Enzymol; 1990; 182():93-112. PubMed ID: 2179675
    [No Abstract]   [Full Text] [Related]  

  • 17. Fusions to staphylococcal protein A.
    Nilsson B; Abrahmsén L
    Methods Enzymol; 1990; 185():144-61. PubMed ID: 2199777
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential stability of recombinant human insulin-like growth factor II in Escherichia coli and Staphylococcus aureus.
    Hammarberg B; Moks T; Tally M; Elmblad A; Holmgren E; Murby M; Nilsson B; Josephson S; Uhlén M
    J Biotechnol; 1990 Jun; 14(3-4):423-37. PubMed ID: 1366914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning, recombinant expression, and characterization of basic fibroblast growth factor.
    Thompson SA; Protter AA; Bitting L; Fiddes JC; Abraham JA
    Methods Enzymol; 1991; 198():96-116. PubMed ID: 1857242
    [No Abstract]   [Full Text] [Related]  

  • 20. Vector pPLEX for expression of nonfusion polypeptides in Escherichia coli.
    Sczakiel G; Maeda K
    Methods Enzymol; 1993; 217():3-11. PubMed ID: 8474336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.